AKT1 and lung carcinoma: Several groups have reported that amplification, mutation, and high levels of phosphorylated AKT in tumor tissues from lung cancer patients correlated with poor prognosis in lung cancer patients in stage I of the disease or with primary tumors [42], [44], [45], [46], [47].